Kiniksa Pharmaceuticals International, plc
KNSA
DELAYED 1 MONTH

14 insider filings · Latest: Jul 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 29, 2026Jul 31 8:34 PMBradley G ColeDirector
Sale
3,673$81.43$299.1K11,672(D)

View →

May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Sale
58,424$53.71$3.1M65,623(D)

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
48,565$54.02$2.6M0(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
2,141$54.01$115.6K0(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
22,544$54.01$1.2M0(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
483,654$51.86$25.1M0(D)

View →

Mar 9, 2026Mar 11 8:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Sale
36,722$45.92$1.7M12,086(D)

View →

Mar 2, 2026Mar 4 9:40 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Sale
40,000$44.82$1.8M61,324(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 9:40 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
40,000$10.3658,424(D)

View →

← Previous

Page 2 of 2